The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease

The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease The FDA recently approved Flourodopa F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […]

Read More

More medications to avoid in Parkinson’s disease?

Data analysis, prescriptions trends and the risk of Parkinson’s disease It is incredibly important when taking any medication(s) to be aware of potential interactions with other drugs or supplements you may also be taking. It can be confusing, especially if you’re taking more than one medication and/or dealing with more than one ailment or disease […]

Read More

Repurposing medications for Parkinson’s disease

Repurposed medications to treat Parkinson’s Disease Repurposing medications is a process by which medications already approved by the Food and Drug Administration (FDA) for one reason are tested and shown to work for another purpose. One great example of this is the use of Amantadine for Parkinson’s disease (PD). Amantadine was first approved for the […]

Read More

Anti-cholinergic Drugs – A Risk Factor For Dementia?

Anti-cholinergic Drugs – A Risk Factor For Dementia?

You may have read that certain medication prescribed for Parkinson’s disease can cause dementia. Dr. Gilbert will weigh in on the science behind this topic, including how these drugs work, and if there’s any casual relationship between them and an increased risk of dementia.

Read More